Literature DB >> 1189536

[Effect of Akrinor on cardiovascular-dynamics before and after blockade of adrenergic beta-receptors by propranolol].

N Sternitzke, H Schieffer, L Bette.   

Abstract

On healthy volunteers it is tested whether the cardiovascular and central stimulating effect of Akrinor and the depressive effect of propranolol influence each other mutually. Akrinor causes an increase in arterial pressure, in cardiac stroke volume and cardiac output in connection with a decrease in peripheral vascular resistance and in heart rate. These changes are abolished by propranolol whereas the central stimulating effect on the respiratory minute volume and the oxygen consumption is not influenced. After blocking of the beta-receptors, Akrinor exerts a diminished influence on the cardiovascular dynamics, a stimulation of the alpha-receptors cannot be evidenced. The findings are being discussed and compared with the effect of noradrenaline and adrenaline.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1189536

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  3 in total

1.  [Old drugs and new approval procedures: Akrinor remains marketable and an application for reapproval of Arginin Vasopressin has been made].

Authors:  T Koch; V Wenzel
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

2.  [Hemodynamic effects of cafedrine/theodrenaline on anesthesia-induced hypotension].

Authors:  M Weitzel; P Hammels; C Schorer; H Klingler; A Weyland
Journal:  Anaesthesist       Date:  2018-08-21       Impact factor: 1.041

Review 3.  Cafedrine/Theodrenaline (20:1) Is an Established Alternative for the Management of Arterial Hypotension in Germany-a Review Based on a Systematic Literature Search.

Authors:  Berthold Bein; Torsten Christ; Leopold H J Eberhart
Journal:  Front Pharmacol       Date:  2017-02-21       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.